The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM, EGM Calendar - Week Ahead

Wed, 29th Apr 2015 05:14

UK AGM, EGM Calendar
Wednesday, April 29
Segro
MTI Wireless Edge
Countrywide
British American Tobacco
Aggreko
Aviva
HellermannTyton
Kennedy Wilson Europe Real Estate
EMIS
Global Invacom Group
Nichols
Admiral
Aberdeen UK Tracker Trust 
Asian Total Return Investment Company 
Devro
Fidessa Group
Lancashire Holdings
Alliance Trust
Weir Group
Polar Capital Global Financials Trust 
EP Global Opportunities Trust
London Stock Exchange Group
Thursday, April 30
Berendsen
Alkane Energy
Colt Group
Ashtead Group
James Fisher & Sons
Synthomer
Ultra Electronics Holdings
Modern Water
Schroders
Tullow Oil
Anglo Pacific
STV Group
Witan Investment Trust
LSL Property
IndigoVision
ARM Holdings
GLI Finance
International Personal Finance
Moneysupermerket.com
RIT Capital Partners
Unilever
Everyman Media Group
Fyffes
BT
H&T Group
Friday, May 1
Aer Lingus
SVG Capital
Jardine Lloyd Thompson Group
Virgin Money
Fairpoint
Electric Word
Capital & Counties Properties
RPS Group
Smurfit Kappa
Silence Therapeutics
Monday, May 4
No Events Scheduled 
Tuesday, May 5
Catlin Group
Randgold Resources
Macfarlane Group
BG Group
Burford Capital
GVC Holdings
Henderson High Income
Spirent Communications
Stratex International
Sherborne Investors
 
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
26 Feb 2021 17:57

LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels

LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels

Read more
26 Feb 2021 09:06

Silence to get $2m milestone payment from Mallinckrodt

(Sharecast News) - Silence Therapeutics announced on Friday that it would receive a $2m (£1.43m) milestone payment following the start of work on a third target being explored under its ongoing RNAi research collaboration with Mallinckrodt, for the treatment of complement pathway-mediated diseases.

Read more
17 Feb 2021 11:57

IN BRIEF: Silence Therapeutics Begins Dosing In SLN360 Phase 1 Trial

IN BRIEF: Silence Therapeutics Begins Dosing In SLN360 Phase 1 Trial

Read more
17 Feb 2021 08:12

Silence Therapeutics begins dosing in lipoprotein treatment trial

(Sharecast News) - Silence Therapeutics has started dosing subjects in the 'APOLLO' phase 1 clinical study of its wholly-owned lead product candidate 'SLN360', it announced on Wednesday, for the treatment of elevated lipoprotein-a (Lp(a)) levels.

Read more
5 Feb 2021 09:34

Silence Therapeutics Raises USD45 Million In Private Share Placing

Silence Therapeutics Raises USD45 Million In Private Share Placing

Read more
5 Feb 2021 09:04

Silence Therapeutics raises ?33m to support pipeline development

(Sharecast News) - Novel therapeutics developer Silence Therapeutics announced an oversubscribed private placement of 2,022,218 American depositary shares (ADSs) on Friday, raising £33m to support the development of its pipeline.

Read more
6 Jan 2021 14:27

UK EXECUTIVE CHANGE SUMMARY: Martin Gilbert Joins River & Mercantile

UK EXECUTIVE CHANGE SUMMARY: Martin Gilbert Joins River & Mercantile

Read more
6 Jan 2021 08:06

Silence Therapeutics taps Craig Tooman for CFO

(Sharecast News) - Drug discovery outfit Silence Therapeutics has named Craig Tooman as its new chief financial officer.

Read more
12 Oct 2020 22:10

UK DIRECTOR DEALINGS SUMMARY: Tesco's Simon Patterson Buys Shares

UK DIRECTOR DEALINGS SUMMARY: Tesco's Simon Patterson Buys Shares

Read more
12 Oct 2020 11:13

e-Therapeutics Names New Chief Executive; Plans To Ramp Up Research

e-Therapeutics Names New Chief Executive; Plans To Ramp Up Research

Read more
8 Oct 2020 21:16

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

Read more
14 Sep 2020 14:07

Silence Therapeutics Appoints Mark Rothera As CEO; Annual Loss Widens

Silence Therapeutics Appoints Mark Rothera As CEO; Annual Loss Widens

Read more
14 Sep 2020 13:14

Mark Rothera joins Silence Therapeutics as new CEO

(Sharecast News) - Drug discovery and development company Silence Therapeutics announced the appointment of Mark Rothera as its president and chief executive officer and board member on Monday, effective immediately.

Read more
8 Sep 2020 19:23

IN BRIEF: Silence Therapeutics ADSs Begin Life On Nasdaq

IN BRIEF: Silence Therapeutics ADSs Begin Life On Nasdaq

Read more
7 Sep 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.